- Home
- PAAI vs DXR Comparison
PAAI vs DXR Comparison
Compare PAAI & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.06
N/A
Current Price
$10.84
Company Overview
Basic Information| Metric | PAAI | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.5M | 59.0M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PAAI | DXR |
|---|---|---|
| Price | $1.06 | $10.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 387.2K | 9.4K |
| Earning Date | N/A | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,892,000.00 | $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $0.98 | $8.56 |
| 52 Week High | $1.19 | $14.76 |
Technical Indicators
Market Signals| Indicator | PAAI | DXR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 57.42 |
| Support Level | N/A | $9.26 |
| Resistance Level | N/A | $10.99 |
| Average True Range (ATR) | 0.00 | 0.56 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 0.00 | 80.47 |
Price Performance
Historical Comparison PAAI
DXR
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.